Tubulocystic renal cell carcinoma in the left kidney: a case report by Yusuke Ishibashi et al.
JOURNAL OF MEDICAL
CASE REPORTS
Ishibashi et al. Journal of Medical Case Reports 2014, 8:265
http://www.jmedicalcasereports.com/content/8/1/265CASE REPORT Open AccessTubulocystic renal cell carcinoma in the left
kidney: a case report
Yusuke Ishibashi, Takuya Koie*, Naoki Fujita, Tendo Satoh, Jotaro Mikami, Shingo Hatakeyama, Chikara Ohyama,
Yuki Tobisawa and Tohru YoneyamaAbstract
Introduction: Tubulocystic renal carcinoma is a rare tumor and has been recently recognized as a neoplastic entity.
We report a case of tubulocystic renal carcinoma in the left kidney and present a review of relevant literature.
Case presentation: A 35-year-old Japanese woman visited our hospital with the chief complaint of left-sided back
pain. Computed tomography revealed a hemorrhagic cyst (size, 7×8cm) in the upper pole of her left kidney.
Approximately 3 years after the initial diagnosis, she complained of left-sided back pain again. Magnetic resonance
imaging revealed an enlarged left renal cyst (size, 10×12cm) with a slightly enhanced cystic wall. The tumor was
clinically diagnosed as a renal cell carcinoma in the cT2N0M0 stage, which arose from the cyst wall; therefore, left
nephrectomy was performed. On histological examination, the tumor showed circumscribed proliferation with
cystically dilated tubules. The tubules and cysts were lined by a single layer of flat, hobnail, and cuboidal cells.
Immunohistochemical analysis revealed that the tumor cells were strongly positive for E-cadherin and P504S.
Conclusions: Examination of more cases of tubulocystic renal carcinoma is required to better understand the
biology of this tumor and to ascertain its prognosis.
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Tubulocystic renal carcinoma (TCRC) is a rare tumor,
and has been recently recognized as a neoplastic entity.
TCRC was not formally described in the World Health
Organization 2004 classification or the guidelines given
in the 2004 Armed Forces Institute of Pathology fascicle
[1,2]; however, Amin et al. were the first to report about
TCRC on the basis of its characteristic morphology [3].
Here we report a case of TCRC in the left kidney and
present a review of the relevant literature.Case presentation
A 35-year-old Japanese woman visited our hospital with
the chief complaint of left-sided back pain. Computed
tomography revealed a hemorrhagic cyst (size, 7×8cm)
in the upper pole of her left kidney (Figure 1). She was
relatively young, but she rejected further examination or
surgical intervention. She was followed-up every 6 months* Correspondence: goodwin@cc.hirosaki-u.ac.jp
Department of Urology, Hirosaki University Graduate School of Medicine,
5 Zaifucho, Hirosaki 036-8562, Japan
© 2014 Ishibashi et al.; licensee BioMed Centra
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.by using magnetic resonance imaging. During the follow-
up period, she did not have any complaints, including
back pain. Approximately 3 years after the initial diagno-
sis, she complained of left-sided back pain again. Magnetic
resonance imaging revealed an enlarged left renal cyst
(size, 10×12cm), with a slightly enhanced cystic wall
(Figure 2). The radiological diagnosis was used to classify
the cyst as a Bosniak type III cyst. The tumor was clinic-
ally diagnosed as a left renal cell carcinoma (RCC) that
arose from the cyst wall, and was classified as a cT2N0M0
tumor, according to the tumor-node-metastasis system.
Left nephrectomy was performed. Macroscopic analysis
of the upper pole of the resected kidney revealed the pres-
ence of clustered smooth-walled cysts with few solid areas
(Figure 3). On histological examination, the tumor showed
circumscribed proliferation with cystically dilated tubules.
The tubules and cysts were lined by a single layer of flat,
hobnail, and cuboidal cells (Figure 4). Papillary structures
were observed within the cysts. Immunohistochemical
analysis revealed that the tumor cells were strongly posi-
tive for E-cadherin and P504S (Figure 5). The tumor cells
did not stain positive for WT1, cytokeratin (CK) 34β12,l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Enhanced abdominal computed tomography. An abdominal computed tomography image showing a hemorrhagic cyst in the
upper pole of the left kidney (arrowheads).
Ishibashi et al. Journal of Medical Case Reports 2014, 8:265 Page 2 of 5
http://www.jmedicalcasereports.com/content/8/1/265transcription factor E3 (TFE3), and CD10 (Figure 6). On
the basis of these findings, she was diagnosed with TCRC
in her left kidney.
Subsequently, she has been followed-up for 5 years
without any evidence of local recurrence or distant
metastasis.
Discussion
Masson originally described TCRC with Bellinian epithe-
lioma as tumors of the collecting ducts of Bellini [4].
Therefore, an evolving concept of collecting duct carcin-
omas was proposed, and low-grade collecting duct car-
cinoma at the beginning of the spectrum corresponds
to the current TCRC [5]. However, by using molecular
clustering, TCRC was found to be more closely related
to papillary RCC than to any other renal neoplasm suchFigure 2 Abdominal magnetic resonance imaging. A T2-weighted magas collecting duct carcinoma [6]. Supportive findings
include the expression of proximal convoluted tubule
markers (CD10 and alpha-methylacyl-CoA racemase;
AMACR), distal nephron proteins (parvalbumin, high-
molecular-weight CK, and CD19) [3,7], and the detec-
tion of intercalated cells and cells similar to those in
the proximal tubule and by using electron microscopy
[3,8,9]. In addition, Alexiev and Drachenberg [10] re-
ported that all TCRCs were strongly positive for the
proximal convoluted tubule markers CD10, vimentin,
and AMACR, but they were only focally positive for
BerEP4 or focally negative for CK34β12, both of which
are distal nephron proteins. By using fluorescence in situ
hybridization and array-based comparative genomic
hybridization, Yang et al. [6] and Zhou et al. [8] have
shown gains in chromosome 17, as is seen in patientsnetic resonance image showing a high-intensity tumor (arrowheads).
Figure 3 Macroscopic findings. A white/gray spongy cut surface measuring 10×12cm in size can be seen in the upper pole of the resected
kidney (arrowheads).
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two entities are closely related.
TCRC is a tumor that occurs in adults with a wide age
range, but most patients present with TCRC in the fifth
or sixth decade [3,6]. There is a strong predominance of
TCRC among men (male/female ratio of 7:1), and ap-
proximately 60% of reported TCRC cases are observed
in the left kidney [3,6]. Patients are often asymptomatic,
although they may present with abdominal pain, abdom-
inal distention, and hematuria [10]. TCRCs are usually
small in size at presentation, with nearly 40% of the re-
ported cases involving tumors that measure ≤2cm [6,7].
On macroscopic examination, TCRCs are circumscribedFigure 4 Hematoxylin-eosin staining. Hematoxylin-eosin-stained section
cells (magnification, 100×).and unencapsulated, and they demonstrate a white or
gray spongy cut surface that is often compared with
“bubble wrap” [6].
The differential diagnosis of TCRC is interesting, and
it mostly includes other tumors with a multiloculated
gross appearance such as multilocular cystic RCC, cystic
nephroma, mixed epithelial and stromal tumors, cystic
oncocytoma, and Xp11.2 RCC [11,12]. Multilocular cys-
tic RCC shows an innate multicystic architecture with
variably sized cystic spaces lined by flattened to cuboidal
clear cells similar to those seen in clear RCC [13,14].
Cystic nephroma shows the presence of multilocular
cysts lined by flattened to attenuated epithelial cells;showing cystically dilated kidney tubules lined with cuboidal and flat
Figure 5 Immunohistochemical findings for P504S. The tumor cells were strongly positive for P504S (magnification, 200×).
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quite prominent [15]. Mixed epithelial and stromal tu-
mors have solid areas and broad septa, in contrast to the
thin fibrous septa of TCRC [10]. Cystic oncocytomas
usually show, at least focally, a solid nest of oncocytic
cells along with loose myxoid stroma [10]. Xp11.2 RCC
with a tubulocystic pattern is rare. Immunohistochemi-
cal analysis for TFE3 and cathepsin K is helpful in
the differential diagnosis of Xp11.2 RCC [16]. The archi-
tecture is predominantly cystic with large cysts and
hyalinized stroma, fibrotic, or may infrequently have an
ovarian stroma-like character [13,17]. TCRC shows theFigure 6 Immunohistochemical findings for cytokeratin 34β12. The tupresence of tightly packed tubules and cysts measuring
up to a few millimeters in diameter, which are separated
by bland fibrous stroma [11]. The lining cells are cu-
boidal to columnar and may have an attenuated appear-
ance [11]. Hobnail cells are commonly observed. Both
TCRCs and cystic nephromas have cysts that are lined
by hobnail cells, but the cells have a low nuclear grade
in cystic nephroma [11]. In addition, the stroma is pauci-
cellular and fibrotic in TCRCs [11].
The biological behavior of TCRCs has not been fully
established. According to previous reports, a total of
six patients have developed metastatic diseases [3,6,11].mor cells were negative for cytokeratin 34β12 (magnification, 200×).
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(9.1%) developed distant metastases to the bone or liver.
Interestingly, the two metastatic tumors displayed areas
of clear cells. Although the majority of tumors behave in
an indolent fashion, one needs to be cautious in render-
ing a prognosis.
Conclusions
TCRCs are a distinctive group of kidney tumors that are
predominant in men, and have noteworthy macroscopic
(“bubble wrap” appearance) and microscopic (cysts lined
with hobnail cells and separated by a thin fibrotic
stroma) characteristics. The examination of more cases
is required to better understand the biology of this
tumor, ascertain its prognosis, and choose the appropri-
ate treatment.
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